Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 401–425 of 566 matching trials (filtered from 7,816) · page 17 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
TMS for Cognitive Decline in Aging and Preclinical AD NCT06956300 Active rTMS; Sham rTMS Runs in: United States · 1 site |
NA other |
RECRUITING | 80 | Massachusetts General Hospital OTHER |
2026-02-20 |
|
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations NCT07424365 transcutaneous auricular vagus nerve stimulation; sham stimulation Runs in: United States · 1 site |
NA other |
RECRUITING | 80 | University of Colorado, Denver OTHER |
2026-02-20 |
|
RCT of HeartBot in Women NCT07416734 HeartBot II Program; Waitlist Control Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 200 | University of California, San Francisco OTHER |
2026-02-18 |
|
Comparing Structured Retrieval Practice and Reading-Based Education for Dementia Caregivers NCT07413406 Structured Retrieval Practice; Reading-Based Education Runs in: United States · 1 site |
NA other |
RECRUITING | 65 | Virginia Wesleyan University OTHER |
2026-02-17 |
|
Evaluating the Efficacy of the Pain Identification and Communication Toolkit NCT06168604 Pain Identification and Communication Toolkit; Health Promotion Program Runs in: United States · 1 site |
NA other |
RECRUITING | 440 | Weill Medical College of Cornell University OTHER |
2026-02-12 |
|
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease NCT06489548 Foralumab TZLS-401 50 µg; Foralumab TZLS-401 100 µg Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 16 | Brigham and Women's Hospital OTHER |
2026-02-12 |
|
Tau PET in Imaging and Cognition: Healthy Adults From 55-90 NCT03372317 18F-MK-6240 Runs in: United States · 1 site |
NA other |
RECRUITING | 105 | Yaakov Stern OTHER |
2026-02-11 |
|
Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease NCT05326451 active tDCS Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | The University of Texas Health Science Center, Houston OTHER |
2026-02-11 |
|
Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms NCT06801639 Transcranial direct current stimulation (tDCS); Sham tDCS Runs in: United States · 1 site |
NA other |
RECRUITING | 24 | The University of Texas Health Science Center at San Antonio OTHER |
2026-02-11 |
|
Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease NCT06843252 Transcranial direct current stimulation (tDCS); Sham tDCS Runs in: United States · 1 site |
NA other |
RECRUITING | 16 | The University of Texas Health Science Center at San Antonio OTHER |
2026-02-11 |
|
Phosphorylated Tau Levels in Donated Blood NCT07157839 Runs in: United States · 1 site |
NA other |
RECRUITING | 250 | The University of Texas Health Science Center, Houston OTHER |
2026-02-11 |
|
Cancer and Mild Cognitive Impairment Dyadic Intervention NCT05144516 Behavioral: COPE + Runs in: United States · 1 site |
NA other |
RECRUITING | 80 | Duke University OTHER |
2026-02-10 |
|
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults NCT07392723 Alpha-Linolenic Acid (2.6 g/day); Placebo Control Group Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 20 | Michal Schnaider Beeri, Ph.D. OTHER |
2026-02-06 |
|
Tennessee Alzheimer's Project NCT05372172 none, observational study Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000 | Vanderbilt University Medical Center OTHER |
2026-02-05 |
|
Cognitive Screening Made Easy for PCPs - Administrative Supplement NCT06928298 RACS app Runs in: United States · 3 sites |
NA other |
RECRUITING | 100 | University of Texas at Austin OTHER |
2026-02-05 |
|
Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk NCT06965686 PERI-MIND Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | University of Chicago OTHER |
2026-02-05 |
|
Retinal Imaging in Neurodegenerative Disease NCT03233646 Retinal and Choroidal Imaging Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | Duke University OTHER |
2026-02-04 |
|
Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD) NCT05205980 Perturbation training Runs in: United States · 1 site |
NA other |
RECRUITING | 30 | Georgia State University OTHER |
2026-02-04 |
|
Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury NCT05762796 tDCS in Youth with mild traumatic brain injury Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | State University of New York at Buffalo OTHER |
2026-02-03 |
|
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease NCT06057909 Magnetic Resonance Imaging; Electroencephalography; Electromyography Runs in: United States · 1 site |
NA other |
RECRUITING | 90 | Mayo Clinic OTHER |
2026-02-03 |
|
Open-label Extension Study in Participants With Early Alzheimer's Disease NCT07105709 GSK4527226 Runs in: Argentina; Australia; Canada; Finland; Norway; South Kore... · 33 sites |
PHASE2 other |
RECRUITING | 220 | GlaxoSmithKline INDUSTRY |
2026-02-02 |
|
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease NCT05795634 Trier Social Stress Test Runs in: United States · 1 site |
NA other |
RECRUITING | 240 | Johns Hopkins University OTHER |
2026-01-29 |
|
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer NCT07377331 Structured Retrieval Practice (SRP) Runs in: United States · 2 sites |
PHASE1 other |
RECRUITING | 60 | Texas Christian University OTHER |
2026-01-29 |
|
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases NCT02649985 [F-18]PBR06; [C-11]PBR28 Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 250 | Brigham and Women's Hospital OTHER |
2026-01-28 |
|
Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance NCT07220694 Sabroxy®; Placebo Runs in: United States · 1 site |
NA other |
RECRUITING | 140 | SF Research Institute, Inc. NETWORK |
2026-01-28 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial